Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
Treatments for Type 2 diabetes and new clinical trial data on glucose sensors and insulin pumps were a focus at this week's Advanced Technologies & Treatments for Diabetes conference. Medtech manufacturers gathered in Amsterdam to discuss the latest innovations for managing diabetes. Here are three highlights from the first day of the conference: Dexcom shared the first data for its 15-day continuous glucose monitor ahead of a Thursday presentation. The new device would give Dexcom a CGM that can be worn for as long as competitor Abbott's Freestyle Libre 3 Plus sensor. COO Jake Leach said in a February earnings call that the company hopes to receive Food and Drug Administration clearance in the second half of the year. Dexcom
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Mizuho to a "strong-buy" rating.MarketBeat
- The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM [CNET News]CNET News
- FDA Approves New DexCom Diabetes Device [Yahoo! Finance]Yahoo! Finance
- 2 Growth Stocks to Buy in the Tariff-Fueled Market Correction [Yahoo! Finance]Yahoo! Finance
- Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/13/25 - Miss
DXCM
Sec Filings
- 3/31/25 - Form 3
- 3/27/25 - Form ARS
- 3/27/25 - Form DEFA14A
- DXCM's page on the SEC website